Wild type and gain of function mutant TP53 can regulate the sensitivity of pancreatic cancer cells to chemotherapeutic drugs, EGFR/Ras/Raf/MEK, and PI3K/mTORC1/GSK-3 pathway inhibitors, nutraceuticals and alter metabolic properties
Journal article published in 2022 by
James A. McCubrey,
Akshaya K. Meher 
,
Shaw M. Akula,
Stephen L. Abrams,
Linda S. Steelman,
Michelle M. LaHair,
Richard A. Franklin,
Alberto M. Martelli,
Stefano Ratti,
Lucio Cocco,
Fulvio Barbaro,
Przemysław Duda,
Agnieszka Gizak
,
Shaw M. Akula,
Stephen L. Abrams,
Linda S. Steelman,
Michelle M. LaHair,
Richard A. Franklin,
Alberto M. Martelli,
Stefano Ratti,
Lucio Cocco,
Fulvio Barbaro,
Przemysław Duda,
Agnieszka Gizak
This paper is made freely available by the publisher.
Full text: Download
Preprint: archiving forbidden
Postprint:
archiving forbidden
Data provided by 